FTRE
VENTE TOTALE: 221 426 titres (~4 107 645,76 $ US)
- Insiders
- Thakral Anshul, SANDERS MACHELLE
- Total bought
- —
- Total sold
- $4,107,646
- Last activity
- 2026-08-06
- Last synced
-
2026-08-12 09:47:22
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-08-06
Despite a genuine earnings beat and raised guidance (catalyst score 75, confidence 0.7), FTRE's underlying financial structure is critically impaired: a current ratio below 1.0, negative interest coverage, negative…
The first sentence of the analysis written for FTRE on 2026-08-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 15.6% | 19.8% | 20.8% | 25.5% | 19.8% | |
| Ebit Margin | -32.7% | -5.6% | 1.4% | 6.6% | 4.5% | |
| Ebitda Margin | -29.9% | -2.4% | 4.8% | 9.9% | 9.9% | |
| Operating Profit Margin | -1.1% | -6.0% | 1.1% | 6.6% | 3.7% | |
| Pretax Profit Margin | -36.1% | -10.2% | -1.1% | 6.6% | 4.5% | |
| Continuous Operations Profit Margin | -36.2% | -10.1% | -1.1% | 5.1% | 3.2% | |
| Net Profit Margin | -36.2% | -12.2% | -0.9% | 6.6% | 3.2% | |
| Bottom Line Profit Margin | -36.2% | -12.2% | -0.9% | 6.6% | 3.2% | |
| Current Ratio | 0.982 | 0.999 | 1.607 | 1.784 | 1.352 | |
| Quick Ratio | 0.982 | 0.999 | 1.607 | 1.784 | 1.352 | |
| Solvency Ratio | -0.422 | -0.109 | 0.028 | 0.296 | 0.239 | |
| Cash Ratio | 0.191 | 0.125 | 0.140 | 0.160 | 0.114 | |
| Price To Earnings Ratio | -1.596 | -5.082 | -872.500 | 15.166 | 28.829 | |
| Price To Earnings Growth Ratio | -0.008 | -0.001 | 8.563 | 0.168 | -0.226 | |
| Forward Price To Earnings Growth Ratio | -0.008 | -0.001 | 8.563 | 0.168 | -0.226 | |
| Price To Earnings Diluted Ratio | -1.596 | -5.082 | -872.500 | 15.166 | 28.829 | |
| Price To Earnings Diluted Growth Ratio | -0.008 | -0.001 | 8.563 | 0.168 | -0.226 | |
| Price To Book Ratio | 2.792 | 1.225 | 1.808 | 0.846 | 0.868 | |
| Price To Sales Ratio | 0.578 | 0.619 | 1.090 | 0.997 | 0.925 | |
| Price To Free Cash Flow Ratio | 17.817 | 7.034 | 24.193 | 99.958 | 19.740 | |
| Price To Operating Cash Flow Ratio | 13.861 | 6.352 | 18.403 | 34.206 | 16.660 | |
| Debt To Assets Ratio | 0.411 | 0.335 | 0.386 | 0.015 | 0.018 | |
| Debt To Equity Ratio | 1.980 | 0.880 | 0.975 | 0.019 | 0.024 | |
| Debt To Capital Ratio | 0.664 | 0.468 | 0.494 | 0.019 | 0.023 | |
| Long Term Debt To Capital Ratio | 0.650 | 0.435 | 0.477 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 4.819 | 2.627 | 2.528 | 1.283 | 1.340 | |
| Working Capital Turnover Ratio | -313.034 | 11.447 | 5.572 | 6.765 | 0.000 | |
| Operating Cash Flow Ratio | 0.124 | 0.277 | 0.216 | 0.118 | 0.205 | |
| Operating Cash Flow Sales Ratio | 0.042 | 0.097 | 0.059 | 0.029 | 0.056 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.778 | 0.903 | 0.761 | 0.342 | 0.844 | |
| Debt Service Coverage Ratio | -8.491 | -0.306 | 1.418 | 1,198.500 | 1,322.500 | |
| Interest Coverage Ratio | -0.335 | -1.308 | 0.458 | 935.500 | 571.500 | |
| Short Term Operating Cash Flow Coverage Ratio | 23.646 | 3.513 | 6.452 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.102 | 0.219 | 0.101 | 1.304 | 2.199 | |
| Capital Expenditure Coverage Ratio | 4.504 | 10.306 | 4.179 | 1.520 | 6.408 | |
| Dividend Paid And Capex Coverage Ratio | 4.504 | 10.306 | 4.179 | 1.520 | 6.408 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -3.091 | -42.755 | 33.983 | 9.901 | 9.282 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 15.6% | ▼-4.2% | ▼-4.7% |
| Ebit Margin | -32.7% | ▼-27.1% | ▼-27.6% |
| Ebitda Margin | -29.9% | ▼-27.5% | ▼-28.3% |
| Operating Profit Margin | -1.1% | ▲4.9% | ▼-2.0% |
| Pretax Profit Margin | -36.1% | ▼-25.9% | ▼-28.8% |
| Continuous Operations Profit Margin | -36.2% | ▼-26.1% | ▼-28.4% |
| Net Profit Margin | -36.2% | ▼-24.0% | ▼-28.3% |
| Bottom Line Profit Margin | -36.2% | ▼-24.0% | ▼-28.3% |
| Current Ratio | 0.982 | ▼-0.016 | ▼-0.362 |
| Quick Ratio | 0.982 | ▼-0.016 | ▼-0.362 |
| Solvency Ratio | -0.422 | ▼-0.313 | ▼-0.428 |
| Cash Ratio | 0.191 | ▲0.066 | ▲0.045 |
| Price To Earnings Ratio | -1.596 | ▲3.486 | ▲165.441 |
| Price To Earnings Growth Ratio | -0.008 | ▼-0.008 | ▼-1.707 |
| Forward Price To Earnings Growth Ratio | -0.008 | ▼-0.008 | ▼-1.707 |
| Price To Earnings Diluted Ratio | -1.596 | ▲3.486 | ▲165.441 |
| Price To Earnings Diluted Growth Ratio | -0.008 | ▼-0.008 | ▼-1.707 |
| Price To Book Ratio | 2.792 | ▲1.567 | ▲1.284 |
| Price To Sales Ratio | 0.578 | ▼-0.041 | ▼-0.264 |
| Price To Free Cash Flow Ratio | 17.817 | ▲10.783 | ▼-15.932 |
| Price To Operating Cash Flow Ratio | 13.861 | ▲7.509 | ▼-4.035 |
| Debt To Assets Ratio | 0.411 | ▲0.076 | ▲0.178 |
| Debt To Equity Ratio | 1.980 | ▲1.101 | ▲1.205 |
| Debt To Capital Ratio | 0.664 | ▲0.197 | ▲0.331 |
| Long Term Debt To Capital Ratio | 0.650 | ▲0.215 | ▲0.338 |
| Financial Leverage Ratio | 4.819 | ▲2.192 | ▲2.300 |
| Working Capital Turnover Ratio | -313.034 | ▼-324.482 | ▼-255.185 |
| Operating Cash Flow Ratio | 0.124 | ▼-0.152 | ▼-0.064 |
| Operating Cash Flow Sales Ratio | 0.042 | ▼-0.056 | ▼-0.015 |
| Free Cash Flow Operating Cash Flow Ratio | 0.778 | ▼-0.125 | ▲0.052 |
| Debt Service Coverage Ratio | -8.491 | ▼-8.184 | ▼-511.215 |
| Interest Coverage Ratio | -0.335 | ▲0.973 | ▼-301.498 |
| Short Term Operating Cash Flow Coverage Ratio | 23.646 | ▲20.133 | ▲16.924 |
| Operating Cash Flow Coverage Ratio | 0.102 | ▼-0.118 | ▼-0.683 |
| Capital Expenditure Coverage Ratio | 4.504 | ▼-5.802 | ▼-0.879 |
| Dividend Paid And Capex Coverage Ratio | 4.504 | ▼-5.802 | ▼-0.879 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -3.091 | ▲39.665 | ▼-4.555 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $1.57B | $1.67B | $3.10B | $2.83B | $2.83B | |
| Enterprise value | $2.51B | $2.75B | $4.66B | $2.78B | $2.81B | |
| EV / Sales | 0.92x | 1.02x | 1.64x | 0.98x | 0.92x | |
| EV / Op. cash flow | 22.16x | 10.46x | 27.69x | 33.62x | 16.56x | |
| EV / Free cash flow | 28.48x | 11.59x | 36.40x | 98.24x | 19.62x | |
| EV / EBITDA | -3.09x | -42.76x | 33.98x | 9.90x | 9.28x | |
| Net debt / EBITDA | -1.16x | -16.80x | 11.39x | -0.17x | -0.06x | |
| Current ratio | 0.98x | 1.00x | 1.61x | 1.78x | 1.35x | |
| Income quality | -0.12x | -0.97x | -6.68x | 0.44x | 1.73x | |
| Graham number | — | — | — | $42 | $30 | |
| Graham net-net | -$17 | -$18 | -$20 | -$1 | -$3 | |
| Tax burden | 100.3% | 119.5% | 82.6% | 99.6% | 71.8% | |
| Interest burden | 110.3% | 181.9% | -77.8% | 99.9% | 99.9% | |
| Working capital | -$16.1M | -$1.3M | $472.4M | $547.9M | $290.8M | |
| Invested capital | $1.72B | $2.52B | $3.11B | $3.53B | $3.47B | |
| Return on assets | -36.3% | -9.2% | -0.6% | 4.3% | 2.2% | |
| Operating ROA | -1.0% | -4.1% | 0.7% | 4.3% | 0.0% | |
| Return on tangible assets | -87.0% | -27.1% | -1.4% | 12.7% | 7.2% | |
| Return on equity | -175.0% | -24.1% | -1.5% | 5.6% | 3.0% | |
| Return on invested capital | -1.7% | -5.9% | 0.9% | 4.0% | 2.3% | |
| Return on capital employed | -1.7% | -6.2% | 0.9% | 5.2% | 3.2% | |
| Earnings yield | -62.7% | -19.7% | -0.8% | 6.6% | 3.5% | |
| Free cash flow yield | 5.6% | 14.2% | 4.1% | 1.0% | 5.1% | |
| Capex / Op. cash flow | 22.2% | 9.7% | 23.9% | 65.8% | 15.6% | |
| Capex / Depreciation | 32.3% | 26.0% | 41.1% | 58.1% | 15.9% | |
| Capex / Sales | 0.9% | 0.9% | 1.4% | 1.9% | 0.9% | |
| SG&A / Sales | 16.8% | 20.8% | 15.8% | 14.7% | 9.9% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 2.7% | 2.2% | 1.5% | 0.9% | 0.9% | |
| Intangibles / Total assets | 58.3% | 66.1% | 57.0% | 65.8% | 69.0% | |
| Days sales outstanding | 83d | 94d | 130d | 135d | 113d | |
| Days payables outstanding | 5d | 23d | 22d | 14d | 9d | |
| Operating cycle | 83d | 94d | 130d | 135d | 113d | |
| Cash conversion cycle | 78d | 71d | 108d | 121d | 104d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▼-5.7%EV / Sales ▼-9.4%EV / EBITDA ▲+92.8%EV / Op. cash flow ▲+11.694Earnings yield ▼-0.430
Profitability
Return on equity ▼-1.509Return on assets ▼-0.271Return on invested capital ▲+0.042Return on capital employed ▲+0.045Operating ROA ▲+0.031Income quality ▲+0.853Tax burden ▼-0.191
Efficiency
Days sales outstanding ▼-10.849Days payables outstanding ▼-18.611Operating cycle ▼-10.849Cash conversion cycle ▲+7.762Capex / Sales -0.000R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.016Net debt / EBITDA ▲+15.639Working capital ▼-14800000.000Invested capital ▼-805700000.000Intangibles / Total assets ▼-0.079
Change over 5 years
Valuation
Market cap ▼-44.4%EV / Sales ▲+0.4%EV / EBITDA ▼-133.3%EV / Op. cash flow ▲+5.598Earnings yield ▼-0.662
Profitability
Return on equity ▼-1.780Return on assets ▼-0.386Return on invested capital ▼-0.040Return on capital employed ▼-0.049Operating ROA n/aIncome quality ▼-1.848Tax burden ▲+0.285
Efficiency
Days sales outstanding ▼-30.291Days payables outstanding ▼-4.284Operating cycle ▼-30.291Cash conversion cycle ▼-26.007Capex / Sales ▲+0.001R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.369Net debt / EBITDA ▼-1.100Working capital ▼-306900000.000Invested capital ▼-1754400000.000Intangibles / Total assets ▼-0.108
Employee count
Peer market caps
Congressional trades
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2025-06-23 | James French Hill | Sale | $1,001 - $15,000 |
Recent news
- 2026-07-31 Fortrea Holdings Inc. (FTRE) Upgraded to Strong Buy: Here''s What You Should Know Fortrea Holdings Inc. (FTRE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
- 2026-07-31 FTRE vs. ARGX: Which Stock Is the Better Value Option? Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Fortrea Holdings Inc. (FTRE) and argenex SE (ARGX). But which of these two companies is the best option for those looking for undervalued stocks?
- 2026-07-31 Best Momentum Stock to Buy for July 31st FTRE, ASML and KLAC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 31, 2026.
- 2026-07-31 Fortrea Holdings Inc. (FTRE) Is Attractively Priced Despite Fast-paced Momentum Fortrea Holdings Inc. (FTRE) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our ''Fast-Paced Momentum at a Bargain'' screen.
- 2026-07-29 Fortrea Holdings Inc. (FTRE) Q2 2026 Earnings Call Transcript Fortrea Holdings Inc. (FTRE) Q2 2026 Earnings Call Transcript
- 2026-07-29 Fortrea Q2 Earnings Call Highlights Fortrea NASDAQ: FTRE reported second-quarter 2026 revenue of $678.2 million and adjusted EBITDA of $58.7 million, while raising its full-year revenue and adjusted EBITDA outlook. Management said results reflected stronger clinical pharmacology performance, cost-savings initiatives and improving commercial activity, particularly among biotechnology clients.
- 2026-07-29 Fortrea Holdings Inc. (FTRE) Surpasses Q2 Earnings and Revenue Estimates Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.19 per share a year ago.
- 2026-07-29 Fortrea Reports Second Quarter 2026 Results Four consecutive quarters of execution to drive commercial, operational and financial excellence Increases full-year guidance
- 2026-07-23 Kaskela Law Firm Announces Investigation of Fortrea Holdings Inc. (FTRE) and Encourages Long-Term FTRE Shareholders with Investment Losses to Contact the Firm PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating Fortrea Holdings Inc. (Nasdaq: FTRE) (“Fortrea”) on behalf of the company''s long-term investors. Click here for additional information: https://kaskelalaw.com/case/fortrea-holdings/ Recently a securities fraud complaint was filed against Fortrea on behalf of certain investors who purchased shares of the company''s stock between July 5, 2023 and February 28, 2025 (the “Wrongdoing Period”). Accor.
- 2026-07-13 Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call DURHAM, N.C., July 13, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its second quarter 2026 financial results before the market opens on Wednesday, July 29, 2026.